CMA

Investors Are Bailing Out of Comerica (CMA). Here's Why.

Comerica stock is trading -26.45% below its average target price of $55.51 after dropping -3.0% during today's afternoon session. Analysts are giving the large-cap Banking company an average rating of buy and target prices ranging from $42.0 to $80.0 per share.

Comerica has an average level of shares sold short, at 7.6% of its total share float. The stock's short ratio (also called days to cover) is 1.55. Only 0.55% of the company's shares are owned by insiders, indicating that management does not have a deep alignment of interest with its shareholders.

Institutional investors own 84.9% of Comerica's shares, which indicates they have a high level of confidence in the company.

Institutions Invested in Comerica

Date Reported Holder Percentage Shares Value
2023-03-31 Vanguard Group, Inc. (The) 13% 17,161,267 $700,694,563
2023-03-31 Blackrock Inc. 10% 13,313,998 $543,610,562
2023-03-31 State Street Corporation 5% 6,442,220 $263,035,854
2023-03-31 First Trust Advisors LP 3% 3,878,506 $158,359,407
2023-03-31 Morgan Stanley 3% 3,457,163 $141,155,971
2023-03-31 Citadel Advisors Llc 2% 3,174,737 $129,624,517
2023-03-31 Charles Schwab Investment Management, Inc. 2% 3,020,358 $123,321,222
2023-03-31 Adage Capital Partners GP L.L.C. 2% 2,971,149 $121,312,019
2023-03-31 Geode Capital Management, LLC 2% 2,824,857 $115,338,916
2023-03-31 Alliancebernstein L.p. 2% 2,265,107 $92,484,322
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS